The American Journal of Managed Care

Population Health Implications of Cardiorenal Metabolic Syndrome

Jeffrey Turner, MD, and Nihar R. Desai, MD, MPH, discuss coordination of care between specialties, and Om P. Ganda, MD, provides insight into the goals of therapy and population health outcomes in ...
The American Journal of Managed Care

Risk Stratification and Care Navigation in Cardiorenal Metabolic Syndrome

Neil Minkoff, MD: When I think about this population and disease state, I’m taking a few of the diagnoses that most concern me, and I’m lumping them together. As people treating this frequently, you ...
Medscape

SGLT2 Inhibitors: A Future in Cardiorenal Metabolic Syndrome

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. He has been a ...
Medscape

A Global Health Tidal Wave? Cardiorenal Metabolic Syndrome

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Chiadi E. Ndumele, ...
Healio

Obesity, more common now in young patients, adds to the burden of cardiorenal syndrome

Please provide your email address to receive an email when new articles are posted on . The Cover Story this month in Healio/ Nephrology News & Issues focuses on obesity and its relationship to ...
Business Insider

Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

HOUSTON, May 25, 2021 /PRNewswire/ -- Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today successful treatment of ...
Business Insider

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Study to be conducted under $3.6 million NIH grant DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing ...
Frontiers

Hypertension and Cardiorenal Syndrome and Their Relationship with Aging: Friends and Foes

Hypertension is a chronic clinical condition characterized by cardiovascular physiological impairment. It occurs when blood ...
Healio

Obesity medications can tackle metabolic cardiorenal disease

The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, cardiovascular disease and overall mortality are well known. Now, there is ...
Morningstar

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

DENVER, May 28, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing ...
Wall Street Journal

AstraZeneca to Buy U.S. Cardiorenal-Drug Maker

Anglo-Swedish pharma giant AstraZeneca PLC has agreed to buy CinCor Pharma Inc., including global rights to its baxdrostat cardiorenal drug, for an upfront transaction value of around $1.3 billion.